article · Journal of Medicine Surgery and Public Health
The advent of 3D printing technology has a great role in cancer research, offering massive opportunities for drug delivery and development. This commentary provides a well-detailed review of the advancements in 3D printing of cancer models, details their application in imitating the complex tumor microenvironment, and enables more meticulous pre-clinical drug testing. We discuss the various 3D printing techniques like “stereolithography”, “selective laser sintering”, and “fused deposition modeling” with their advantages, effects, and limitations. The commentary also makes headway on the critical problem in these vascular networks. In extension, we explore the future perspectives of 3D-printed cancer models, emphasizing the potential for personalized medicine and high–throughput screening. By accentuating these advancements and challenges, we aim to provide a roadmap for future research and development in the use of 3D printing for cancer drug discovery, contributing to more effective and patient-centric cancer treatments.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.glmedi.2024.100165
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.